Latest News about FDA
Recent news which mentions FDA
FDA Approval Brings Some Good News For Bankrupt Lucira Health
February 27, 2023
Tickers
LHDX
From Benzinga
FDA Slams Break On Fulcrum Therapeutics' Sickle Cell Disease Study, Shares Plummet
February 24, 2023
Tickers
FULC
From Benzinga
CBD: FDA Advisor Calls For Fair Rules Amid SAMSHA's Critical Report On Side Effects And Unknowns
February 24, 2023
From Benzinga
Pfizer/BioNTech Seek Expanded Approval For Its Updated COVID-19 Shot As Primary Series Vaccination
February 24, 2023
From Benzinga
4D Molecular Discloses Updated Data From Currently Paused Fabry Disease Cardiomyopathy Study
February 23, 2023
Tickers
FDMT
From Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
From Benzinga
Why Chemomab Therapeutics Shares Are Trading Higher Today
February 21, 2023
Tickers
CMMB
From Benzinga
FDA Gives Green Signal To Chemomab Therapeutics' Rare Disease Study
February 21, 2023
Tickers
CMMB
From Benzinga
Why Are Apellis Pharmaceuticals Shares Trading Higher Today?
February 21, 2023
Tickers
APLS
From Benzinga
Travere Therapeutics Scores Accelerated FDA Approval For Rare Kidney Disease Treatment
February 21, 2023
From Benzinga
Pfizer, Valneva Discontinue Certain Trial Sites For Phase 3 Study Of Lyme Disease Vaccine Candidate
February 17, 2023
From Benzinga
Pfizer Releases Interim Update On PARP Inhibitor Combo Therapy For Prostate Cancer, Secures FDA Priority Review
February 16, 2023
Tickers
PFE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.